Discovery uncovers clue to disarm gonorrhea superbug

March 30, 2018, Monash University
(L-R): Dr. Pankaj Deo and Dr. Thomas Naderer from the Monash Biomedicine Discovery Institute. Credit: Monash University

Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhoea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 per cent rise in gonorrhoea in Australia over the past five years.

Gonorrhoea is caused by bacteria which can rapidly develop resistance to all known antibiotics—commonly called 'superbugs'. Gonorrhoea superbugs have now been detected in every Australian state and territory and are increasingly difficult to treat in the clinic.

Monash University researchers have discovered a way the gonorrhoea bacteria cleverly evade the immune system—opening up the way for therapies that prevent this process, allowing the body's natural defences to kill the bug.

Published today in PLOS Pathogens, Dr. Thomas Naderer and Dr. Pankaj Deo and their team from the Monash Biomedicine Discovery Institute, have discovered how the gonorrhoea-causing superbug (which is very small) creates even smaller packages of bacterial membrane blebs, termed vesicles, which attack .

Using cutting-edge super-resolution microscopy, which is able to see, and film, the most minute of events—the researchers found that these interacted with the cells in the human immune system called 'macrophages', triggering these to die in an orchestrated suicide process. Macrophages are the cells within the immune system that ordinarily kill foreign invaders like bacteria and viruses, so without them the gonorrhoea bacteria can flourish.

Dr. Naderer said that this new understanding of how the gonorrhoea bacteria interact and cause the death of "may lead to strategies to combat infection and its symptoms".

The research may also provide information as to how other evade the immune system and be unaffected by antibiotics. The 2016 Review on Antimicrobial Resistance Final Report and Recommendations states that antibiotic resistant infection will kill an extra 10 million people a year worldwide—more than currently die from cancer—by 2050 unless action is taken.

The full paper in PLOS Pathogens is titled 'Outer membrane vesicles from Neisseria gonorrhoeae target PorB to mitochondria and induce apoptosis.'

Explore further: New drugs needed against gonorrhoea: UN

More information: PLOS Pathogens, DOI: 10.1371/1006945

Related Stories

New drugs needed against gonorrhoea: UN

July 7, 2017
New drugs are urgently needed to treat gonorrhoea, a sexually-transmitted disease threatening to veer out of control as it develops resistance to existing antibiotics, the UN's health agency said Friday.

Reviving old drugs could help to stem the rise of drug-resistant gonorrhoea

November 1, 2017
A new study suggests a drug that was used in the past to treat gonorrhoea could help tackle infections that are resistant to current treatments.

New antibiotic class found effective against gonorrhea in the laboratory

August 7, 2017
The World Health Organisation (WHO) has estimated that 700,000 people around the world die annually from drug resistant infections. It also listed drug resistant gonorrhoea, a sexually transmitted disease caused by the Neisseria ...

Push to control gonorrhoea as resistance threat looms

December 15, 2017
Australia's rising number of gonorrhoea cases has been described as a potential 'perfect storm', with the emergence of extensively drug resistant strains overseas.

WHO urges shift in STD treatment due to antibiotic resistance (Update)

August 30, 2016
Growing resistance to antibiotics has complicated efforts to rein in common sexually transmitted diseases like gonorrhoea, chlamydia and syphilis, the World Health Organization warned Tuesday as it issued new treatment guidelines.

Scientists develop new antibiotic for gonorrhoea

January 4, 2017
Scientists at the University of York have harnessed the therapeutic effects of carbon monoxide-releasing molecules to develop a new antibiotic which could be used to treat the sexually transmitted infection gonorrhoea.

Recommended for you

Experimental vaccine shows promise in preventing TB

September 25, 2018
(HealthDay)—Tuberculosis remains the most lethal of infectious diseases worldwide, killing more than 1.6 million people a year. But researchers say a new vaccine might prevent half of full-blown illnesses in infected people ...

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Researchers seek vaccine for 'traveler's diarrhea'

September 25, 2018
Every year, millions of people have vacations and business trips ruined when they succumb to "traveler's diarrhea" during their journeys. A major cause of traveler's diarrhea is bacteria called Enterotoxigenic E. coli, or ...

Many doctors in India miss TB signs: study

September 25, 2018
Many private sector doctors in India miss the signs of tuberculosis and therefore provide patients inadequate treatment, according to a new study published Tuesday involving people hired to act out the symptoms.

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Osiris1
2 / 5 (1) Mar 31, 2018
All cases of 'Siff'...syphillis, 'TB' ... tuberculosis, and 'Lepers' .... leprosy, etc, were once housed lifelong in colonies to separate them from further spreading their diseases. We may have to rethink the old ways in the light of the apparent fact that we ARE headed there AGAIN! Facilitating this will require new laws and court tests to adjudicate the 'right to spread disease in the pursuit of a living' issues as well as disposing of wealth based immunity to isolations issues..... (rich will not 'wanna go' and may buy their own twisted 'justice') Such should not be horrid places of no hope, but pleasant places for them to spend the rest of there shortened lives.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.